
Melasma Treatment Advances: Non-Ablative Laser and Tranexamic Acid Combination Explained
Max Thorne posted on LinkedIn:
“Enhancing Melasma Treatment: Benefits of Non-Ablative Laser and Tranexamic Acid”
Understanding the Study on Melasma Treatment
This study looked at a new way to treat melasma, a skin condition that causes dark patches on the face. It combined two treatments: a non-ablative fractional laser (NAFL) and a topical medication called tranexamic acid (TXA). The goal was to see if this combination works better than using TXA alone.
What Worked?
The combination of NAFL and TXA showed better results in reducing melasma compared to TXA alone right after treatment.
Patients felt more satisfied with the results when using both treatments.
What Didn’t Work?
While there was improvement right after treatment, the benefits did not last long-term. Melasma returned in both groups during follow-ups.
After one and three months, there was no significant difference in results between the two treatment sides.
How Does This Help Patients and Clinics?
For patients, this study suggests that combining NAFL with TXA can provide quick improvements in melasma. However, it also highlights the need for ongoing treatment to maintain results. Clinics can use this information to offer more effective treatment options.
Real-World Opportunities
Clinics can start offering the combination treatment of NAFL and TXA for patients with melasma.
Doctors can educate patients about the potential for short-term improvement and the possibility of recurrence.
Measurable Outcomes to Track
Track changes in melasma severity using a standard scoring system.
Monitor patient satisfaction regularly after treatment.
Keep records of how long the results last before melasma returns.
AI Tools to Consider
Clinics might explore AI tools that can help analyze skin conditions or predict treatment outcomes based on patient data. These tools can assist in personalizing treatment plans.
Step-by-Step Plan for Clinics
Start by training staff on the new treatment combination of NAFL and TXA.
Begin with a small group of patients to monitor results and gather feedback.
Gradually expand the treatment offering based on initial success and patient satisfaction.
Regularly assess and adjust treatment plans based on patient outcomes and feedback.
For more details on the research, you can read the full study here.
Source
Title: Efficacy of Non-Ablative Fractional Laser Combined With Tranexamic Acid in Melasma Treatment: A Randomized Split-Face Trial
Authors: Amirhossein Rahimnia, Motahareh Hosnian, Amir houshang Ehsani, Pedram Nourmohammadpour, Zahra Shadlou, Mina Koohian Mohammadabadi, Ala Ehsani
Keep up with Hemostasis Today.
-
Oct 21, 2025, 05:20Ewa Fiorentino Rozek: APS - When “Unprovoked” Clots And Pregnancy Loss Connect
-
Oct 21, 2025, 03:503 Questions With Abigail Ajanel Gomez – Touch Haematology Future Leader 2025
-
Oct 21, 2025, 01:57Mohamed Reda: Clotting Factors — The Key Players in Blood Coagulation
-
Oct 20, 2025, 12:46Linda Hayes Bennett on The Terrain-Level Determinants of Ischemic Stroke
-
Oct 20, 2025, 06:24AABB: Viscoelastic Testing in Patient Blood Management: Friend or Foe?
-
Oct 21, 2025, 11:13Hanny Al Samkari's Commentary on Iron Deficiency Anemia in Inherited Bleeding Disorders
-
Oct 21, 2025, 11:08Wolfgang Miesbach on New Real-World Data for Haemophilia B Prophylaxis
-
Oct 21, 2025, 05:54John Strouse on Hydroxyurea for Children with Sickle Cell Disease
-
Oct 20, 2025, 12:33Emmanuel J Favaloro Shares Summary Table To Understand The Complexity of von Willebrand Factor
-
Oct 20, 2025, 12:17Alexander Hermann and Colleagues On Post-ECMO Thrombosis
-
Oct 21, 2025, 06:18Katerina Akassoglou Receives Zenith Fellows Award to Advance Alzheimer’s Research
-
Oct 16, 2025, 06:07ClearPlasma - A New Breakthrough in Stopping Life-Threatening Bleeds
-
Oct 14, 2025, 05:26Ryan C. Heniford: Every Thrombus Prevented Is a Patient Protected
-
Oct 13, 2025, 04:48Archil Jaliashvili showcases how BHOC builds on Hemopure’s success to revolutionize surgery and care
-
Oct 13, 2025, 02:46Flora Peyvandi: First Proposed Blood Test for Chronic Fatigue Syndrome - What Scientists Think
-
Oct 21, 2025, 11:11Nana Kwame Kwabi Boateng: Grateful For The Opportunity to Serve As A SEARCH Ambassador
-
Oct 21, 2025, 05:00Sheila Cristina Ouriques Martins Is Grateful to Be Among The Legends Who Changed The Reality of Stroke Worldwide
-
Oct 21, 2025, 01:47Cathy Bliem: Yesterday, I Made My 4th Plasma Donation of 2025...
-
Oct 20, 2025, 12:40Asfand Yar Cheema: Honored to be featured in Video Journal of Hematology and Hematological Oncology
-
Oct 20, 2025, 12:25Laurent Bertoletti Highlights Evolving Role of Anticoagulation in Pulmonary Hypertension Treatment